1.
Boccadoro M, Tarella C, Palumbo A, Argentino C, Triolo S, Dominietto A, Callea V, Lauta V, Molica S, Musto P, Marmont F, Gianni A, Pileri A. An analysis of which subgroups of multiple myeloma patients, divided according to b(2)-microglobulin and plasma cell labeling index, benefit from high dose vs conventional chemotherapy. Haematologica [Internet]. 1999Oct.1 [cited 2026Nov.17];84(10):905-10. Available from: https://haematologica.org/article/view/1497